MDCL - Medicine Man Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.1700
-0.0300 (-0.94%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.2000
Open3.2350
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.9000 - 3.2350
52 Week Range1.0600 - 4.1700
Volume133,555
Avg. Volume125,653
Market Cap88.713M
Beta (3Y Monthly)1.45
PE Ratio (TTM)N/A
EPS (TTM)-0.0810
Earnings DateApr 30, 2019 - Apr 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire

    Medicine Man Technologies Announces Record Second Quarter 2019 Results

    - Second Quarter Total Revenue Grows by 24% Year-Over-Year - Second Quarter Highlighted by 249% Increase in Product Revenue - Company to Host Q2 2019 Financial Results Conference Call on Thursday, August ...

  • GlobeNewswire

    Wall Street Reporter presents: “Next Super Stock - Live!” August 15, 2019

    NEW YORK, Aug. 14, 2019 -- Wall Street Reporter will be hosting the “Next Super Stock - Live!” livestream online-only investor conference on Thursday August 15, 2019 from.

  • PR Newswire

    Medicine Man Technologies, Inc. to Host Q2 2019 Conference Call on August 15, 2019

    DENVER, Aug. 13, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), today announced that the Company will host a conference call to discuss operational and financial highlights from its second quarter 2019 on Thursday, August 15, 2019 at 4:15 p.m. ET. A live webcast will be available on the Company's website at https://ir.medicinemantechnologies.com.

  • Benzinga

    Medicine Man Enters Binding Agreement To Buy Colorado Extract Brand Dabble

    Medicine Man Technologies, Inc. (OTC: MDCL) said Monday it has entered into a binding term sheet with the award-winning Colorado-based cannabis concentrate brand Dabble Extracts. Under the terms of the agreement, Medicine Man will pay $3,75 million for the company: $750,000 in cash and 996,678 common stock shares at $3.01 each. Medicine Man said it pursued the acquisition for a number of strategic benefits.

  • Medicine Man Technologies, Inc. Announces Binding Term Sheet to Acquire Dabble Extracts, an Award-Winning Cannabis Extract Company
    PR Newswire

    Medicine Man Technologies, Inc. Announces Binding Term Sheet to Acquire Dabble Extracts, an Award-Winning Cannabis Extract Company

    DENVER, Aug. 12, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company") today announced that the Company has entered into a binding term sheet to acquire Colorado-based Dabble Extracts, an award-winning cannabis concentrate company that specializes in processing medical and recreational marijuana into premium-grade extracts.

  • ACCESSWIRE

    Medicine Man Technologies Featured on the Stock Day Podcast

    PHOENIX, AZ / ACCESSWIRE / July 29, 2019 / Host of Stock Day Podcast, Everett Jolly, welcomed Medicine Man Technologies (MDCL) (“the Company”), a rapidly growing provider of cannabis consulting services, nutrients, and growing supplies, in a recent interview with Co-Founder and CEO Andy Williams. In the episode, Jolly and Williams discussed the recent Colorado legislature, House Bill (HB) 19 - 1090, which Williams helped write.

  • Benzinga

    Former Albertsons CEO Ups His Medicine Man Tech Investment To $21M

    Medicine Man Technologies Inc (OTC: MDCL) announced that Dye Capital & Company is increasing its investment in the company from $14 million to $21 million. Justin Dye, Dye Capital Management Partner, is stepping up to serve as Medicine Man Technologies' Chairman of the Board. Dye was a leader in Albertsons Companies as it expanded its transactions to over $40 billion.

  • PR Newswire

    Medicine Man Technologies Closes on Second Phase of Strategic Investment from Dye Capital & Company

    DENVER, July 17, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), today announced that the Company has amended its original securities purchase agreement (SPA) dated June 5, 2019, with strategic partner Dye Capital & Company. At the initial closing, the Company issued and sold 1,500,000 common shares and warrants to purchase 1,500,000 shares of common stock, for gross proceeds of $3 million. Medicine Man Technologies and Dye Capital also completed on July 15, the second closing from the SPA, with Dye Capital purchasing 3,500,000 shares of Company stock for $7 million and receiving warrants to purchase 3,500,000 shares of common stock at an exercise price of $3.50.

  • Benzinga

    Medicine Man Technologies Appoints Lee Dayton As Chief Administrative Officer

    Medicine Man Technologies Inc (OTC: MDCL ) said Monday it appointed Albertsons Companies veteran Lee Dayton as its new Chief Administrative Officer. As Medicine Man Technologies' Chief Administrative Officer, ...

  • Medicine Man Technologies, Inc., Taps Lee Dayton as Chief Administrative Officer
    PR Newswire

    Medicine Man Technologies, Inc., Taps Lee Dayton as Chief Administrative Officer

    DENVER, July 1, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today announced that business strategist industry veteran, Lee A. Dayton, Jr. will join the Company as Chief Administrative Officer. In his new role, Mr. Dayton will utilize his knowledge of technology, corporate finance and e-commerce to help Medicine Man Technologies optimize its acquisition and integration strategies and pursue additional growth levers as the Company becomes a fully vertically integrated operator.

  • PR Newswire

    Update - Medicine Man to Host Conference Call Today, Tuesday June 25th at 4:15pm ET

    Call to Discuss Recent Announcements of Pending Acquisitions and Additional Members of Its Executive Management Team DENVER , June 25, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ...

  • Medicine Man Technologies, Inc. Announces Appointments of New Chief Strategy Officer and VP of Integration
    PR Newswire

    Medicine Man Technologies, Inc. Announces Appointments of New Chief Strategy Officer and VP of Integration

    DENVER, June 18, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today announced the appointments of Todd Williams as Chief Strategy Officer and Collin Lodge as Vice President of Integration.

  • PR Newswire

    Medicine Man Technologies, Inc. to Host Corporate Update Call on Recently Announced and Pending Developments

    Management to Host Call on Tuesday, June 25 at 4:15 p.m. ET DENVER , June 13, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), ...

  • Benzinga

    Medicine Man Technologies Makes Third M&A Deal Of The Month, Plans to Acquire Colombia's Green Equity

    The vertically integrated company said Wednesday that it entered into a binding term sheet with the Colombian company Green Equity S.A.S. to acquire 100% of its assets. Medicine Man will pay $5.4 million for the company. If approved, the deal will consist of $450,000 in cash as well as 1,292,427 shares of Medicine Man common stock at $3.83 a share.

  • PR Newswire

    Medicine Man Technologies, Inc. Announces Strategic Expansion into Colombia with Binding Term Sheet to Acquire Green Equity S.A.S.

    - Acquisition will provide Company with international licenses and IP for cultivation, manufacturing, extraction, exportation, and R&D - Deal marks Company's third pending M&A transaction this month as ...

  • MarketWatch

    Medicine Man Technologies to sell up to $14 million of stock to PE firm Dye Capital

    Medicine Man Technologies Inc. said Thursday it has entered a share sale agreement with private-equity firm Dye Capital & Co. for up to $14 million. The Denver, Colorado-based company will use the funds to finance growth and pending acquisitions, that include research and phytopharmaceuticals company Medicine Man Denver, Los Sueños Farms and cannabis products maker Mesa Organics. Two members of Dye Capital's board, Justin Dye and Leo Rivera, will join the Medicine Man board and Dye, who is managing partner, will become chairman. Dye Capital specializes in investments in the cannabis sector. Before founding Dye Capital, Justin Dye was part of the private-equity consortium that acquired supermarket chain Albertsons Companies. Medicine Man shares were not active premarket, but like many players in the new and speculative cannabis sector, have enjoyed outsize gains this year, rising 204% in 2019 to date, while the S&P 500 has gained 13%.

  • PR Newswire

    Medicine Man Technologies Closes on First Phase of Initial $14 Million Strategic Investment from Dye Capital & Company

    DENVER, June 6, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, announced today that it has entered into a securities purchase agreement for the sale of up to $14 million of the Company's common stock from an affiliate of Dye Capital & Company ("Dye Capital"). Dye Capital is a private equity firm with extensive experience in aggressively growing and scaling businesses in retail and consumer brands. The Company will invest in expansion of its brand presence, scaling product development, retail innovation, operational capabilities and corporate infrastructure.

  • Benzinga

    Medicine Man Technologies Makes 2 Cannabis Acquisitions In Colorado

    Medicine Man Technologies, Inc. (OTC: MDCL ) announced it will acquire Colorado-based cannabis farm, Los Sueños Farms, LLC, and cannabis dispensary Mesa Organics Ltd. These acquisitions will increase Medicine ...

  • GlobeNewswire

    Emerging Market Leaders: E-Commerce in Africa - Blockchain/Mobile - Cannabis - Beverages

    NEW YORK, June 05, 2019 -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published interviews with CEO’s of some of today’s most talked.

  • Medicine Man Technologies, Inc. Announces Entry into Binding Term Sheets for Two Strategic Cannabis Acquisitions
    PR Newswire

    Medicine Man Technologies, Inc. Announces Entry into Binding Term Sheets for Two Strategic Cannabis Acquisitions

    DENVER, June 5, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today is pleased to announce that it has entered into binding term sheets to acquire the assets and rights from Colorado-based Los Sueños Farms, LLC, North America's largest sustainable cannabis farm. The Company has also entered into a binding term to acquire Mesa Organics Ltd (d/b/a Purplebee's), Mesa Organics II Ltd. and Mesa Organics III Ltd. (collectively "MesaPur"), a leading cannabis dispensary and infused products manufacturing company, utilizing pure CO2 extracts from the finest locally-grown cannabis in Colorado.

  • Medicine Man Technologies Commends Passage of Colorado HB19-1090 Following Governor Polis' Signing of Bill Into Law
    PR Newswire

    Medicine Man Technologies Commends Passage of Colorado HB19-1090 Following Governor Polis' Signing of Bill Into Law

    DENVER, May 30, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today cited the signing of the Colorado House Bill 19-1090 by Colorado Governor Jared Polis and applauded the passage of the bill. House Bill 19-1090 was introduced in January to repeal the provisions that prohibit publicly traded companies from holding a marijuana license. Sponsored by Representatives Gray and Van Winkle and Senators Gonzales and Hill, the bill went through the House and Senate Committees over the course of four months.

  • PR Newswire

    Medicine Man Technologies, Inc. to Participate on Cannabis Panel at the 39th Annual Piper Jaffray Consumer Marketplace Conference

    DENVER, May 28, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated operator, today announced that the Company will be featured on a cannabis panel at the 39th Annual Piper Jaffray Consumer Marketplace Conference, being held on Thursday, June 6, 2019 at the Pierre New York in New York City. Medicine Man Technologies is a profitable first mover in the cannabis industry, having recently reported a 65% yearly growth increase in total revenue and acquisition strategy to continue to rapidly grow for the first quarter of 2019. Piper Jaffray is a leading investment bank and asset management firm.

  • PR Newswire

    Medicine Man Technologies, Inc. to Present at the 9th Annual LD Micro Invitational

    DENVER, May 24, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated operator, today announced that it will be presenting at the 9th Annual LD Micro Invitational, to be held on June 4 -5, 2019 at the Luxe Sunset in Bel Air, California. Mr. Joe Puglise, Chief Operating Officer of Medicine Man Technologies, will deliver a corporate presentation and discuss the Company's recent highlights at 10:40 a.m. PT on Tuesday, June 4, 2019. LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

  • PR Newswire

    Medicine Man Technologies Releases Record First Quarter 2019 Financial Results

    First Quarter Highlighted by 65% Yearly Growth in Total Revenue and 236% Yearly Product Revenue Growth DENVER , May 21, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine ...

  • PR Newswire

    Medicine Man Technologies, Inc. to Present at the 2019 ThinkEquity Conference

    DENVER, April 30, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today announced that it will be presenting at the ThinkEquity Conference, to be held on Thursday, May 2, 2019 at the Mandarin Oriental Hotel in New York City. Joe Puglise, Chief Operating Officer of Medicine Man Technologies, will deliver a presentation and discuss recent Company highlights at 12:00 p.m. ET in the Lotus West Room. Medicine Man Technologies is a profitable first mover in the cannabis industry, with a revenue run rate expected at $40-50 million upon completion of its pending acquisitions.